Viewing Study NCT06752759


Ignite Creation Date: 2025-12-24 @ 2:32 PM
Ignite Modification Date: 2026-02-05 @ 8:50 AM
Study NCT ID: NCT06752759
Status: RECRUITING
Last Update Posted: 2024-12-31
First Post: 2024-12-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nebulized Ketamine for the Treatment of Major Depressive Disorder in an Inpatient Setting
Sponsor: Theresa Jacob, PhD, MPH
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Severe Depression View
None Moderate Depression View
None Ketamine View
None Midazolam View
None Peripheral Nervous System Agents View
None Central Nervous System Agents View
None Neurotransmitter Agents View
None Physiologic Effects of Drugs View
None Sensory System Agents View
None Analgesics, Non-Narcotic View
None Anti-Inflammatory Agents, Non-Steroidal View
None Depressive Symptom View
None Hypnotics and Sedatives View
None Anti-anxiety Agents View
None Tranquilizing Agents View
None Psychotropic Drugs View
None Anesthetics Agent View
None GABA Modulators View
None GABA Agents View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Maimonides Medical Center View
None Psychiatry View
None Ketamine View
None Midazolam View
None Peripheral Nervous System Agents View
None Sensory System Agents View
None Anesthetics, Dissociative View
None Nebulized Medications for depression View
None GABA Agents View